Which COVID Vaccine Is ‘Best’? Why Do Some People Have Side Effects? Experts Answer These Questions and More
Scientific American talked to scientists about everything from what efficacy means to protection against the new coronavirus variants
Scientific American talked to scientists about everything from what efficacy means to protection against the new coronavirus variants
Pharmaceutical companies are starting clinical trials in young children and adolescents, but they must balance speed and safety
Researchers gave shots to politicians and family members, violating trial regulations—and damaging public trust
Manaus and cities like it will continue to generate dangerous viral variants if vaccination campaigns are not expanded to broadly reach all nations, rich or poor
The pandemic gives an opportunity to turn the tide for our nation’s most vulnerable communities
Pandemic highlights for the week
Today we bring you the third episode in a new podcast series: COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Phone calls may be integral to connecting with people who are lonely and isolated
A now familiar 21st-century scenario of circumventing public-health strictures played out as well at the beginning of the 20th century
Undercounting or ignoring cases of the disease on the continent could lead to new variants that might derail efforts to end the pandemic
SARS-CoV-2 may be settling into a limited set of mutations
A hunger strike in Chicago and concerns raised by city and state politicians have slowed the planned move of a metal scrapper to a working-class, predominantly Latino community
Differences in life expectancy, car ownership and language may contribute to the racial and ethnic disparities
Human behavior and social inequity are huge confounding factors
Pandemic highlights for the week
The New York Times columnist discusses police brutality, racial disparities of the pandemic and diversifying the workplace
Willingness is rising, even among skeptical groups, at a time when there are still not enough doses to go around
Uptake by patients and physicians has been low in the U.S. even though some therapies have been authorized for months
The decline suggests the vaccine is having an effect even though workers have been slower to take it than residents
Research shows that the benefits may outweigh the drawbacks
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account